Financhill

Annual Reports

Per Page: 24
Company
Score
Last Price
Annual Revenues
Last Price:
136.37
Annual Revenues:
6.83B
Return on Equity:
21.32%
Last Price:
26.32
Annual Revenues:
20.59B
Return on Equity:
8.75%
Last Price:
6.61
Annual Revenues:
20.59B
Return on Equity:
8.75%
Last Price:
169.89
Annual Revenues:
383.29B
Return on Equity:
159.97%
Last Price:
17.42
Annual Revenues:
9.3B
Return on Equity:
11.6%
Last Price:
48.87
Annual Revenues:
32.24B
Return on Equity:
26.65%
Last Price:
167.29
Annual Revenues:
54.32B
Return on Equity:
36.83%
Last Price:
2.30
Annual Revenues:
15.98B
Return on Equity:
17.04%
Last Price:
163.01
Annual Revenues:
9.92B
Return on Equity:
72.17%
Last Price:
106.86
Annual Revenues:
40.11B
Return on Equity:
15.22%
Last Price:
23.33
Annual Revenues:
15.38B
Return on Equity:
4.05%
Last Price:
9.02
Annual Revenues:
5.47B
Return on Equity:
11.63%
Last Price:
0.44
Annual Revenues:
98.2B
Return on Equity:
9.75%
Last Price:
11.28
Annual Revenues:
98.2B
Return on Equity:
9.75%
Last Price:
93.05
Annual Revenues:
13.29B
Return on Equity:
29.56%
Last Price:
19.91
Annual Revenues:
79.24B
Return on Equity:
58.13%
Last Price:
93.59
Annual Revenues:
14.38B
Return on Equity:
2.4%
Last Price:
309.00
Annual Revenues:
64.11B
Return on Equity:
26.55%
Last Price:
46.05
Annual Revenues:
5.47B
Return on Equity:
11.63%
Last Price:
473.44
Annual Revenues:
19.41B
Return on Equity:
31.26%
Last Price:
121.59
Annual Revenues:
23.2B
Return on Equity:
-1.35%
Last Price:
197.94
Annual Revenues:
12.31B
Return on Equity:
7.84%
Last Price:
61.00
Annual Revenues:
93.94B
Return on Equity:
13.92%
No results

Investing News

How High Will Madrigal Pharmaceuticals Go?

How High Will Madrigal Pharmaceuticals Go?

The FDA said yes to Madrigal Pharmaceuticals’ (MDGL) new drug, Rezdiffra, which led to its stock price shooting up but the momentum quickly subsided so what does the future hold? As the biotechnology industry is once again bubbling with prominent mergers and acquisitions, accelerated FDA approvals, and breakthrough developments, now may be as good a […]

Read Article

Why Did Bill Gates Buy Berkshire Hathaway?

Why Did Bill Gates Buy Berkshire Hathaway?

Bill Gates is a technology icon. Warren Buffett is an investing icon. The two men also happen to be very good friends with a three-decade-long relationship. Over that time, they have partnered on many ventures, both political and philanthropic. Because of the friendship the two men share, it may come as no surprise that Gates, […]

Read Article

Why Did Buffett Invest In Chevron? 

Why Did Buffett Invest In Chevron? 

Warren Buffett, the guru of value investing best known buying and holding stock has been snapping up shares of Chevron Corporation (NYSE:CVX), one of the most prominent energy companies. Buffett-controlled Berkshire Hathaway reduced its Chevron holding initially last year but in Q4 the company unexpectedly changed its course from selling to buying 15.8 million shares. […]

Read Article

How Did Deborah Meaden Make Her Money?

How Did Deborah Meaden Make Her Money?

Deborah Meaden grew up in an entrepreneurial household, but she didn’t start her life rich. Her family owned an amusement arcade that she eventually came to manage when she grew older. Today, Deborah Meaden is best known as an investor on the BBC show Dragons’ Den. The show’s name is derived from its original Japanese […]

Read Article

1 Warren Buffett ETF To Buy?

1 Warren Buffett ETF To Buy?

One reason the “Oracle of Omaha” became a billionaire was because he took early stakes in some of the biggest brands in the world, including Apple and Coca-Cola. But it wasn’t just his stock-picking prowess that earned the world-famous investor his accolades. Indeed one researcher recently claimed Buffett’s real skill was figuring out how to […]

Read Article

Are AI Stocks Overvalued?

Are AI Stocks Overvalued?

After a spectacular run in 2023, AI stocks finally appear to be running out of steam. Top stocks in the field have fallen drastically in recent weeks, and the NASDAQ composite as a whole is down more than 5% in the past 30 days. Does this mean that AI stocks have peaked, or are high-growth […]

Read Article

More Investing News

The #1 Stock Analysis Tool to Make Smarter Buy and Sell Decisions

Get started at Financhill, the #1 investment research platform that is your one-stop shop for finding the best trade ideas today.

  • Top Rated Stock Ideas
    Financhill Stock Score is a proprietary stock rating engine that independently evaluates every company based on fundamental, technical, and sentiment criteria so you can find the highest rated stocks in the S&P 500, NASDAQ and NYSE.
  • Best Stock Tools Platform
    Whether you are looking for the best blue chip stocks, top dividend stocks, most shorted stocks, cheapest stocks today, highest dividend stocks or best stocks under $50, Financhill has got you covered and has so much more.
  • Stocks Set To Soar & Crash
    Financhill spots seasonal patterns in thousands of stocks so you can easily screen for the best stocks at this time of year. Want to know what stocks could rise 11% over the next 7 weeks with 91% accuracy based on past history? Our Seasonality Screener will surface the hottest stocks right now.
Learn More

Featured in:

CNBC
The Wall Street Journal
Chicago Tribune
Barrons
MSN
Reuters